Systemic and inhaled fluoroquinolone antibiotics - Important Safety Information from Marketing Authorisation Holders of products containing Ciprofloxacin, Delafloxacin, Levofloxacin, Moxiflaxacin as approved by the HPRA (12.06.23)

Notice type: 3rd Party Publications

Date: 12/06/2023

Important Safety Information from Marketing Authorisation Holders regarding systemic and inhaled fluoroquinolone antibiotics (Ciprofloxacin, Delafloxacin, Levofloxacin, Moxifloxacin) – Reminder on restrictions of use